NDRA
NDRA
NASDAQ · Health Care

Endra Life Sciences Inc

$4.35
-0.24 (-5.23%)
As of Mar 29, 11:03 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +643.4% upside
Low Target $22.21
Average Target $32.34
High Target $49.71
Current Price $4.35
Current
$4.35
Target
$32.34
$22.21 $32.34 avg $49.71
Scenario Analysis
Bear Case
$22.21
410.6%
Low target
Base Case
$32.34
+643.4%
Avg target
Bull Case
$49.71
+1,042.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$11.96
-63.6% from high
52-Week Low
$2.90
+50.0% from low
Target vs 52W High
$32.34
+170.4% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +8.6%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +20.3%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -52.3%
SYK
Stryker Corp
Strong Buy 37 76% $338.36 +3.0%
MDT
Medtronic Plc
Buy 38 63% $192.46 +122.1%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -74.9%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -64.5%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +117.3%